MCRB (STOCKS)
Seres Therapeutics, Inc.
$8.990000
+0.670000 (+8.05%)
Prev close: $8.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Richard N. Kender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $83.59M
- Employees
- 103
- P/E (TTM)
- 12.96
- P/B (TTM)
- 1.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.78 | $-2.15 | +0.3722 | +17.29% |
|
Sep 2025 (Q3)
|
$0.94 | $1.31 | -0.3656 | -28.00% |
|
Jun 2025 (Q2)
|
$-2.27 | $-2.54 | +0.2724 | +10.71% |
|
Mar 2025 (Q1)
|
$-2.96 | $-0.55 | -2.4092 | -437.40% |
Financial Statements
| Revenues | $789.00K |
| Benefits Costs and Expenses | -$4.91M |
| Costs And Expenses | -$4.91M |
| Nonoperating Income/Loss | $99.67M |
| Operating Expenses | $94.76M |
| Research and Development | $49.06M |
| Other Operating Expenses | $45.70M |
| Operating Income/Loss | -$93.97M |
| Income/Loss From Continuing Operations After Tax | $5.70M |
| Income/Loss From Continuing Operations Before Tax | $5.70M |
| Income/Loss From Discontinued Operations Net Of Tax | $0.00 |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | $5.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $5.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.64 |
| Diluted Earnings Per Share | $0.64 |
| Basic Average Shares | 8,858,975 |
| Diluted Average Shares | 8,869,742 |
| Assets | $138.19M |
| Current Assets | $49.38M |
| Noncurrent Assets | $88.82M |
| Fixed Assets | $7.64M |
| Other Non-current Assets | $81.18M |
| Liabilities | $93.98M |
| Current Liabilities | $19.32M |
| Accounts Payable | $1.68M |
| Wages | $2.69M |
| Other Current Liabilities | $14.96M |
| Noncurrent Liabilities | $74.65M |
| Equity | $44.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $44.22M |
| Liabilities And Equity | $138.19M |
| Net Cash Flow From Operating Activities | $1.12M |
| Net Cash Flow From Operating Activities, Continuing | $1.12M |
| Net Cash Flow From Investing Activities | -$42.00K |
| Net Cash Flow From Investing Activities, Continuing | -$42.00K |
| Net Cash Flow From Financing Activities | $13.90M |
| Net Cash Flow From Financing Activities, Continuing | $13.90M |
| Net Cash Flow | $14.97M |
| Net Cash Flow, Continuing | $14.97M |
| Comprehensive Income/Loss | $5.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $5.70M |
| Other Comprehensive Income/Loss | $5.70M |
| Other Comprehensive Income/Loss Attributable To Parent | $0.00 |